Remove Microdosing Remove Research and Development Remove Treatment
article thumbnail

Exploring Microdosing: A Comprehensive Guide to Minimal Cannabis Consumption

United Patients Group

United Patients Group is dedicated to providing the latest information and research surrounding medical marijuana, empowering readers to make informed decisions about their health journey. In the sections that follow, we will delve deeper into the principles of microdosing medical marijuana.

article thumbnail

Press Release: PsiloThera, Inc. a Leader in Psychedelic Healthcare Innovation Announces the Filing of U. S. Patents Protecting Its Proprietary Psychedelic Therapeutic Process, Tele-Mental Healthcare & Microdosing Online Platform

Cannabis Law Report

is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. Patents Protecting Its Proprietary Psychedelic Therapeutic Process and Tele-Mental Health & Microdosing Platform.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A.I.-Designed Drugs to Advance Healthcare, Research & Treatment Options

NewsMunchies

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

article thumbnail

New Zealand Government Grants $650K For LSD Microdosing Trials

Cannabis Law Report

together with research collaborators at the University of Auckland , have received NZ$1.44 million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). — MindBio Therapeutics (@MindBioTherap) July 10, 2022.

article thumbnail

Press Release: Origin Therapeutics Announces First Five Portfolio Companies

Cannabis Law Report

integrates the latest developments in neuroscience and neurobiology to create a novel approach to mental health and well-being. is focused on the development, production, and marketing of psychedelic-based products, as legally permitted, with clinically proven efficacy. Dimensions Health Centres Inc. Xpira Pharmaceuticals Inc.

article thumbnail

Legal Acceptance of Cannabis Could Encourage Lawmakers to Embrace Magic Mushrooms

Veriheal

has funneled her energy into simplifying the process of conducting psychedelic research. Well-funded psychedelics research programs that took place in the mid-20th century—all of which were carried out legally—hypothesized that controlled psilocybin use could offer a host of benefits for people with psychiatric problems. milligrams.

article thumbnail

Press Release: Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And Research Centre

Cannabis Law Report

The proposed phase I dosing study will aim to find the optimal microdose or low dose of psilocybin that provides general enhancements to mood, memory, sleep, and other measures of general well-being without any hallucinogenic effects. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (

Therapy 52